Global Pharma, Biopharma Patent Laws In Spotlight At CPhI’s Pharma IPR Conference in India 08/01/2014 by Intellectual Property Watch Leave a Comment An upcoming conference in Mumbai, India will look at patent laws related to the pharmaceutical and biopharma industries regionally and internationally. CPhI’s 3rd Annual Pharma IPR 2014, taking place from 26-28 February, is a targeted conference focusing on patent related matters for pharma and biopharma industry across the globe. It is intended to provide an ideal learning and networking platform where techno-legal experts from patent law firms across the globe share an update on patent regimes, changes in patent laws, and enforceability of patent laws in different regions with the pharma and biopharma companies. The conference agenda will cover most debated subjects like: inter-partes review; one year after the implementation of the America Invents Act; reverse payments settlements cases; current implementation of the Unitary Patent System in the EU; and formulating strategies to introduce generic products in international markets. The programme will cover patent laws of over 13 regions including the US, EU, Japan, Mexico, Canada, India, South East Asia, and Gulf Corporation Council (GCC) countries. Click here to view the region-wise agenda. Free download for IP-Watch Readers! Click here to view presentations from 2013!
US, China Agree On IPR Measures, Including Training Of Chinese Officials 20/12/2013 by William New, Intellectual Property Watch Leave a Comment The United States and China today announced agreements on a series of measures to strengthen intellectual property rights protection in China.
Special Report: US IP Attachés Report To US Industry On Activities Abroad 19/12/2013 by William New, Intellectual Property Watch 1 Comment WASHINGTON, DC – The United States Patent and Trademark Office (USPTO) programme of strategically placed intellectual property lawyers in key locations abroad continues to grow. And the annual report of a lineup of these IP attachés this week at the US Chamber of Commerce showed they are having some success.
Developing Countries Lack Capacity To Take Advantage Of Marrakesh Treaty 18/12/2013 by Catherine Saez, Intellectual Property Watch 7 Comments The 2013 Marrakesh Treaty has been applauded by beneficiaries throughout the world for answering the need for wider access to special format works for visually impaired people. However, the path to its implementation, even after it is ratified by enough countries, appears to be strewn with difficulties in developing countries, which will need capacity-building, according to a speaker at a discussion panel organised by the World Intellectual Property Organization.
Swiss Group Finds Patent-Related Ethical Violations By Pharma Overseas 17/12/2013 by Intellectual Property Watch 1 Comment The Berne Declaration, a Swiss non-profit, has released results of investigations that found industry-sponsored offshore clinical drug trials in developing countries involve “multiple ethical violations,” a problem increased by the patent-based industry business model.
WIPO Assembly: Potential Design Treaty Misses Train To Russia In June, Still On Track For 2014 13/12/2013 by Catherine Saez, Intellectual Property Watch 2 Comments It took World Intellectual Property Organization members long hours in informal consultations over the past two days and far into last night to try solving two outstanding issues in the extraordinary session of the organisation’s General Assembly. Yet another extraordinary session is on the way in May to try to agree on the convening of a diplomatic conference – a high level treaty negotiation – on industrial designs later in 2014.
Future Scenarios, IP Tax Evasion, Informal Sector, And Patents In Africa 13/12/2013 by William New, Intellectual Property Watch Leave a Comment CAPE TOWN, SOUTH AFRICA – A conference here on intellectual property, innovation and the public interest included a look at different possible futures for Africa, global IP tax evasion schemes, a discussion of the strong informal sector, and some views on the relative weakness of patent quality on the continent.
The EU-Thailand FTA: What Fate For Access To Medicines? 12/12/2013 by Intellectual Property Watch Leave a Comment Following the public outcry over the EU’s demands for stringent intellectual property rules that would dramatically raise medicines prices in India, you would expect the EU to think twice about making similar demands in future trade agreements, particularly with low- and middle-income countries. Yet, this is precisely what is going on now in the negotiations for a free trade agreement between the EU and Thailand, writes Tessel Mellema.
Medicines Patent Pool Strikes Deal With Bristol-Myers Squibb 12/12/2013 by Intellectual Property Watch Leave a Comment The Medicines Patent Pool today announced a new agreement with biopharmaceutical company Bristol-Myers Squibb for an HIV medicine, which is expected to increase access in 110 developing countries.
Convergence Of Who’s Who In IP, Innovation, Public Interest In Africa 12/12/2013 by William New, Intellectual Property Watch 2 Comments CAPE TOWN, SOUTH AFRICA – Academics, advocates, lawyers, government officials and others meeting this week have heard of the launch of several new books and research tools to better understand the relationship of intellectual property, development and social issues. In particular, discussion in the early part of the conference focussed on a book revealing evidence from extensive primary research on the ground in 13 countries across the continent.